Secondary Logo

Share this article on:

Current World Literature

Bibliography

This bibliography is produced in association with Current Opinion in Cardiology (Lippincott Williams & Wilkins, USA) and is compiled from the journals listed below. Each issue of Coronary Artery Disease lists papers relevant to coronary artery disease published over a one- to two-month period.

This issue consists of literature scanned during 01 January 2000-15 February 2000.

Back to Top | Article Outline

List of journals scanned

The Index Medicus abbreviation is given in parentheses

American Heart Journal (Am Heart J)

American Journal of Cardiology (Am J Cardiol)

Atherosclerosis (Atherosclerosis)

British Medical Journal (BMJ)

Cardiovascular and Interventional Radiology (Cardiovasc Intervent Radiol)

Cardiovascular Research (Cardiovasc Res)

Catheterization and Cardiovascular Diagnosis (Cathet Cardiovasc Diagn)

Circulation (Circulation)

Circulation Research (Circ Res)

Coronary Artery Disease (Coronary Artery Dis)

European Heart Journal (Eur Heart J)

International Journal of Cardiac Imaging (Int J Card Imaging)

International Journal of Cardiology (Int J Cardiol)

Japanese Heart Journal (Jpn Heart J)

Journal of Cardiovascular Pharmacology (J Cardiovasc Pharmacol)

Journal of Cardiovascular Surgery (J Cardiovasc Surg (Torino))

Journal of the American College of Cardiology (J Am Coll Cardiol)

Lancet (Lancet)

New England Journal of Medicine (N Engl J Med)

PACE Pacing and Clinical Electrophysiology (PACE Pacing Clin Electrophysiol)

Thrombosis and Haemostasis (Thromb Haemost)

Back to Top | Article Outline

Arrhythmias

Olshansky B., Hartz V., Hahn E., Mason J., Weaver M.D.: Location of death (In-hospital or out-of-hospital) and type of death (Arrhythmic, nonarrhythmic, noncardiac) after inducible sustained ventricular tachyarrhythmias after syncope, sustained ventricular tachycardia, or nonfatal cardiac arrest (The ESVEM Trial). Am J Cardiol 2000, 86846-851.

Back to Top | Article Outline

Atheromatous Coronary Artery Disease

Chakhtoura E.Y., Shamoon F.E., Haft J.I., Obiedzinski G.R., Cohen A.J., Watson R.M.: Comparison of platelet activation in unstable and stable angina pectoris and correlation with coronary angiographic findings. Am J Cardiol 2000, 86835-839.

Grayston J.T.: Secondary prevention antibiotic treatment trials for coronary artery disease. Circulation 2000, 1021742-1743.

Lindahl B., Toss H., Siegbahn A., Venge P., Wallentin L.: Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. N Engl J Med 2000, 3431139-1147.

Moreno P.R., Murcia A.M., Palacios I.F., Leon M.N., Bernardi V.H., Fuster V., Fallon J.T.: Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus. Circulation 2000, 1022180-2184.

Sunagawa O., Shinzato Y., Touma T., Tomori M., Fukiyama K.: Differences between coronary hyperresponsiveness to ergonovine and vasospastic angina. Jpn Heart J 2000, 41257-268.

Tiefenbacher C.P., Bleeke T., Vahl C., Amann K., Vogt A., Kubler W.: Endothelial dysfunction of coronary resistance arteries is improved by tetrahydrobiopterin in atherosclerosis. Circulation 2000, 1022172-2179.

Back to Top | Article Outline

Cardiac Failure

Gupta S., Prahash A.J.C., Anand I.S.: Myocyte contractile function is intact in the post-infarct remodeled rat heart despite molecular alterations. Cardiovasc Res 2000, 4877-88.

Back to Top | Article Outline

Etiology

Aleksic N., Juneja H., Folsom A.R., Ahn C., Boerwinkle E., Chambless L.E., Wu K.K.: Platelet PlA2 allele and incidence of coronary heart disease -<TB> Results from the atherosclerosis risk in communities (ARIC) study. Circulation 2000, 1021901-1905.

Ariyo A.A., Haan M., Tangen C.M., Rutledge J.C., Cushman M., Dobs A., Furberg C.D.: Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Circulation 2000, 1021773-1779.

Kark J.D., Gordon E.S., Haklai Z.: Coronary heart disease mortality among Arab and Jewish residents of Jerusalem. Lancet 2000, 3561410-1411.

Kawashiri M., Kajinami K., Nohara A., Yagi K., Inazu A., Koizumi J., Mabuchi H.: Effect of common methylenetetrahydrofolate Reductase gene mutation on coronary artery disease in familial hypercholesterolemia. Am J Cardiol 2000, 86840-845.

Lowe G., Rumley A., Norrie J., Ford I., Shepherd J., Cobbe S., Macfarlane P., et al: Blood rheology, cardiovascular risk factors, and cardiovascular disease: The West of Scotland Coronary Prevention Study. Thromb Haemost 2000, 84553-558.

Muhlestein J.B., Horne B.D., Carlquist J.F., Madsen T.E., Bair T.L., Pearson R.R., Anderson J.L.: Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease. Circulation 2000, 1021917-1923.

Nemeroff C.B., Musselman D.L.: Are platelets the link between depression and ischemic heart disease?. Am Heart J 2000, 140557-562.

Nemeroff C.B., OConnor C.M.: Depression as a risk factor for cardiovascular and cerebrovascular disease: Emerging data and clinical perspectives - Introduction. Am Heart J 2000, 140555-556.

OConnor C.M., Gurbel P.A., Serebruany V.I.: Depression and ischemic heart disease. Am Heart J 2000, 140563-569.

SteffenBatey L., Nichaman M.Z., Goff D.C., Frankowski R.F., Hanis C.L., Ramsey D.J., Labarthe D.R.: Change in level of physical activity and risk of all-cause mortality or reinfarction - The Corpus Christi Heart Project. Circulation 2000, 1022204-2209.

VandenHoogen P.C.W., Seidell J.C., Menotti A., Kromhout D.: Blood pressure and long-term coronary heart disease mortality in the Seven Countries Study: implications for clinical practice and public health. Eur Heart J 2000, 211639-1642.

Zito F., Drummond F., Bujac S.R., Esnouf M.P., Morrissey J.H., Humphries S.E., Miller G.J.: Epidemiological and genetic associations of activated factor XII concentration with factor VII activity, fibrinopeptide A concentration, and risk of coronary heart disease in men. Circulation 2000, 1022058-2062.

Back to Top | Article Outline

Interventional Cardiology

Baldus S., Koster R., Elsner M., Walter D.H., Arnold R., AuchSchwelk W., Berger J., et al: Treatment of aortocoronary vein graft lesions with membrane-covered stents - A multicenter surveillance trial. Circulation 2000, 1022024-2027.

Kyriakides Z.S., Kremastinos D.T., Kolettis T.M., Tasouli A., Antoniadis A., Webb D.J.: Acute endothelin-A receptor antagonism prevents normal reduction of myocardial ischemia on repeated balloon inflations during angioplasty. Circulation 2000, 1021937-1943.

Back to Top | Article Outline

Lipids

AgerholmLarsen B., TybjaergHansen A., Schnohr P., Steffensen R., Nordestgaard B.G.: Common cholesteryl ester transfer protein mutations, decreased HDL cholesterol, and possible decreased risk of ischemic heart disease - The Copenhagen City Heart Study. Circulation 2000, 1022197-2203.

Hulley S.B., Grady D., Browner W.S.: Statins: underused by those who would benefit. BMJ 2000, 321971-972.

Packard C.J., OReilly D.S.J., Caslake M.J., McMahon A.D., Ford I., Cooney J., Macphee C.H., et al: Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. N Engl J Med 2000, 3431148-1155.

Pignone M., Phillips C., Mulrow C.: Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials. BMJ 2000, 321983-986.

RodriguezPorcel M., Lerman A., Ritman E.L., Wilson S.H., Best P.J.M., Lerman L.O.: Altered myocardial microvascular 3D architecture in experimental hypercholesterolemia. Circulation 2000, 1022028-2030.

Sacks F.M., Tonkin A.M., Shepherd J., Braunwald E., Cobbe S., Hawkins C.M., Keech A., et al: Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors - The prospective pravastatin pooling project. Circulation 2000, 1021893-1900.

Sacks F.M., Tonkin A.M., Shepherd J., Braunwald E., Cobbe S., Hawkins C.M., Keech A., et al: Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors -<TB> The prospective pravastatin pooling project. Circulation 2000, 1021893-1900.

Teo K.K., Burton J.R., Buller C.E., Plante S., Catellier D., Tymchak V., Dzavik V., et al: Long-term effects of cholesterol lowering and angiotensin-converting enzyme inhibition on coronary atherosclerosis - The Simvastatin/Enalapril Coronary Atherosclerosis Trial (SCAT). Circulation 2000, 1021748-1754.

Back to Top | Article Outline

Myocardial Infarction

Birnbaum Y., Wagner G.S., Gates K.B., Thompson T.D., Barbash G.I., Siegel R.J., Granger C.B., et al: Clinical and electrocardiographic variables associated with increased risk of ventricular septal defect in acute anterior myocardial infarction. Am J Cardiol 2000, 86830-834.

Fisher S.D., Zareba W., Moss A.J., Marder V.J., Sparks C.E., Hochman J., Liang C.S., et al: Effect of smoking on lipid and thrombogenic factors two months after acute myocardial infarction. Am J Cardiol 2000, 86813-818.

Hirata N., Sakai K., Sakaki S., Ohtani M., Nakano S., Matsuda H.: Assessment of perioperative predictive factors influencing survival in patients with postinfarction ventricular septal perforation - Classified by the site of myocardial infarction. J Cardiovasc Surg (Torino) 2000, 41547-552.

Morrow D.A., Antman E.M., Charlesworth A., Cairns R., Murphy S.A., deLemos J.A., Giugliano R.P., et al: TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation - An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 2000, 1022031-2037.

Ojio S., Takatsu H., Tanaka T., Ueno K., Yokoya K., Matsubara T., Suzuki T., et al: Considerable time from the onset of plaque rupture and/or thrombi until the onset of acute myocardial infarction in humans - Coronary angiographic findings within 1 week before the onset of infarction. Circulation 2000, 1022063-2069.

Prahash A.J.C., Gupta S., Anand I.S.: Myocyte response to Β-adrenergic stimulation is preserved in the noninfarcted myocardium of globally dysfunctional rat hearts after myocardial infarction. Circulation 2000, 1021840-1846.

Prahash A.J.C., Gupta S., Anand I.S.: Myocyte response to beta-adrenergic stimulation is preserved in the noninfarcted myocardium of globally dysfunctional rat hearts after myocardial infarction. Circulation 2000, 1021840-1846.

Back to Top | Article Outline

Pharmacological Management

Antony I., Chemla D., Lerebours G., Nitenberg A.: Restoration of flow-dependent coronary dilation by ACE inhibition improves papaverine-induced maximal coronary blood flow in hypertensive patients: Demonstration that large epicardial coronary arteries are more than conductance vessels. J Cardiovasc Pharmacol 2000, 36570-576.

English K.M., Steeds R.P., Jones T.H., Diver M.J., Channer K.S.: Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina -<TB> A randomized, double-blind, placebo-controlled study. Circulation 2000, 1021906-1911.

Ganne F., Vasse M., Beaudeux J.L., Peynet J., Francois A., Mishal Z., Chartier A., et al: Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits urokinase/urokinase-receptor expression and MMP-9 secretion by peripheral blood monocytes - A possible protective mechanism against atherothrombosis. Thromb Haemost 2000, 84680-688.

Hsia J., Simon J.A., Lin F., Applegate W.B., Vogt M.T., Hunninghake D., Carr M.: Peripheral arterial disease in randomized trial of estrogen with progestin in women with coronary heart disease - The heart and estrogen/progestin replacement study. Circulation 2000, 1022228-2232.

Ishikawa K., Miyataka M., Kanamasa K., Hayashi T., Takenaka T., Inoki T., Katayama K., et al: beta-blockers reduce the incidence of cardiac events in post-myocardial infarction patients. Jpn Heart J 2000, 41279-294.

Muhlestein J.B., Anderson J.L., Carlquist J.F., Salunkhe K., Horne B.D., Pearson R.R., Bunch T.J., et al: Randomized secondary prevention trial of azithromycin in patients with coronary artery disease -<TB> Primary clinical results of the ACADEMIC study. Circulation 2000, 1021755-1760.

Sekiguchi K., Kanda T., Ono Z., Tanaka T., Yokoyama T., Aihara Y., Toyama T., et al: Augmented responses of angiotensin I and II in patients with ischemic heart disease - Relation to left ventricular function. Jpn Heart J 2000, 41269-278.

Back to Top | Article Outline

Restenosis

Boerwinkle E., Hixson J.E., Hanis C.L.: Peeking under the peaks - Following up genome-wide linkage analyses. Circulation 2000, 1021877-1878.

Chande M.: Sulindac prevents restenosis after angioplasty in rodents. Lancet 2000, 3561333.

Mintz G.S., Weissman N.J., Pappas C., Waksman R.: Positive remodeling, regression of in-stent neointimal hyperplasia, and late stent malapposition in the absence of brachytherapy. Circulation 2000, 102E111.

Back to Top | Article Outline

Risk Stratification following Myocardial Infarction

Giannitsis E., Lehrke S., Wiegand U.K.H., Kurowski V., MullerBardorff M., Weidtmann B., Richardt G., et al: Risk stratification in patients with inferior acute myocardial infarction treated by percutaneous coronary interventions - The role of admission troponin T. Circulation 2000, 1022038-2044.

Back to Top | Article Outline

Surgery

Yokoyama Y., Chaitman B.R., Hardison R.M., Guo P., Krone R., Stocke K., Gussak I., et al: Association between new electrocardiographic abnormalities after coronary revascularization and five-year cardiac mortality in BARI randomized and registry patients. Am J Cardiol 2000, 86819-824.

Back to Top | Article Outline

Imaging Techniques

Burger A.J., Notarianni M.P., Aronson D.: Safety and efficacy of an accelerated dobutamine stress echocardiography protocol in the evaluation of coronary artery disease. Am J Cardiol 2000, 86825-829.

Back to Top | Article Outline

Thrombolysis, Fibrinilysis and Reperfusion

Collen D., Sinnaeve P., Demarsin E., Moreau H., DeMaeyer M., Jespers L., Laroche Y., et al: Polyethylene glycol-derivatized cysteine-substitution variants of recombinant staphylokinase for single-bolus treatment of acute myocardial infarction. Circulation 2000, 1021766-1772.

Topol E.J., Ohman E.M., Armstrong P.W., Wilcox R., Skene A.M., Aylward P., Simes J., et al: Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction - Results from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III trial. Circulation 2000, 1021761-1765.

© 2001 Lippincott Williams & Wilkins, Inc.